Amber Busser, DO
Psychiatry · Columbus, OHNPI 1861690018
Payments from drug & device makers
Across 10 payments — averaging $26.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axsome Therapeutics, Inc.$95
- Vanda Pharmaceuticals Inc.$44
- Bausch Health US, LLC$30
- Sunovion Pharmaceuticals Inc.$28
- Avanir Pharmaceuticals, Inc.$20
- Jazz Pharmaceuticals Inc.$18
- plus $28 from 2 others
What the payments were for
- Food & beverage$264100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axsome Therapeutics, Inc. | 1 | $95 |
| Vanda Pharmaceuticals Inc. | 2 | $44 |
| Bausch Health US, LLC | 2 | $30 |
| Sunovion Pharmaceuticals Inc. | 1 | $28 |
| Avanir Pharmaceuticals, Inc. | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| Neurocrine Biosciences, Inc. | 1 | $17 |
| AbbVie | 1 | $12 |
How this compares
$264 in reported general payments places this provider in the 55th percentile of 1,119 psychiatry providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 13 | $41,348 |
| TrintellixVortioxetine Hydrobromide | 13 | $5,752 |
| Duloxetine Hcl | 64 | $3,456 |
| Aripiprazole | 23 | $2,618 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 13 | $2,376 |
| Lurasidone Hcl | 16 | $1,884 |
| Bupropion XlBupropion Hcl | 62 | $1,710 |
| Buspirone Hcl | 51 | $1,518 |
| Quetiapine Fumarate | 73 | $1,330 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 50 | $1,187 |
| Hydroxyzine Hcl | 19 | $795 |
| Trazodone Hcl | 60 | $716 |
| Sertraline Hcl | 48 | $533 |
| Clozapine | 19 | $504 |
| Bupropion Hcl SrBupropion Hcl | 19 | $416 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Columbus
- Fred RomeoColumbus$2.3M
- Michael SaribalasColumbus$1.2M
- Kevin WareColumbus$1.1M
- Kevin ReevesColumbus$286K
- Dallas ErdmannColumbus$125K
- Daniel LeeColumbus$113K
- Peter ZafiridesColumbus$109K
- Shishuka MalhotraCanton$15M
- Henry NasrallahCincinnati$3.8M
- Otto DuenoDayton$3.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.